Protalix BioTherapeutics
Develops and manufactures plant-cell-derived enzyme therapies for rare diseases.
$2.58
After-hours close+0.05 (+1.87%)
At close$2.54(−2.87%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.02 | — | — |
| Aug 2026 | −$0.01 | $0.05 | +600.0% |
| May 2026 | −$0.01 | $0.22 | +2,300.0% |
| Mar 2026 | $0.01 | −$0.07 | −800.0% |
| Nov 2025 | $0.06 | $0.03 | −50.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Oct 2020 | |||
| Aug 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.02 | — | — | $13.4M | — | — |
| Aug 12, 2026 | −$0.01 | $0.05 | +600.0% | $13.0M | $19.9M | +53.6% |
| May 13, 2026 | −$0.01 | $0.22 | +2,300.0% | $11.5M | $33.8M | +193.5% |
| Mar 18, 2026 | $0.01 | −$0.07 | −800.0% | $18.3M | $9.1M | −50.1% |
| Nov 13, 2025 | $0.06 | $0.03 | −50.0% | $14.2M | $17.9M | +25.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 14, 2025 | ||||||
| May 9, 2025 | ||||||
| Mar 17, 2025 | ||||||
| Nov 14, 2024 | ||||||
| Aug 14, 2024 | ||||||
| May 10, 2024 | ||||||
| Mar 14, 2024 | ||||||
| Nov 6, 2023 | ||||||
| Aug 7, 2023 | ||||||
| May 4, 2023 | ||||||
| Feb 27, 2023 | ||||||
| Nov 14, 2022 | ||||||
| Aug 15, 2022 | ||||||
| May 16, 2022 | ||||||
| Mar 31, 2022 | ||||||
| Nov 15, 2021 | ||||||
| Aug 16, 2021 | ||||||
| May 14, 2021 | ||||||
| Mar 30, 2021 | ||||||
| Oct 29, 2020 | ||||||
| Aug 10, 2020 | ||||||
| Jun 1, 2020 | ||||||
| Mar 12, 2020 | ||||||
| Nov 7, 2019 | ||||||
| Aug 8, 2019 | ||||||
| May 6, 2019 | ||||||
| Mar 18, 2019 | ||||||
| Nov 7, 2018 | ||||||
| Aug 9, 2018 | ||||||
| May 9, 2018 | ||||||
| Mar 6, 2018 | ||||||
| Nov 8, 2017 | ||||||
| Aug 9, 2017 | ||||||
| May 10, 2017 | ||||||
| Mar 16, 2017 | ||||||
| Nov 9, 2016 | ||||||
| Aug 8, 2016 | ||||||
| May 9, 2016 | ||||||
| Mar 8, 2016 | ||||||
| Nov 9, 2015 | ||||||
| Aug 10, 2015 | ||||||